Panagora Asset Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History
Bought
Maintained
Sold
Other funds holding SGMO
WA
CS
RCMU
Panagora Asset Management's SGMO Position: Q2 2022 in Review
Panagora Asset Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2022, closing a stake of 199,945 shares — an estimated $1.16M sold.
Panagora Asset Management first reported a position in SGMO in Q1 2015 and held it in 15 quarters. The position peaked at $10.2M in Q4 2020. 188 funds tracked by Wall St. Rank hold SGMO as of Q2 2022.
- Panagora Asset Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2022 after selling out during the quarter.
- Panagora Asset Management sold 199,945 SANGAMO THERAPEUTICS INC shares in Q2 2022, an estimated $1.16M.
- Panagora Asset Management first reported a position in SANGAMO THERAPEUTICS INC in Q1 2015 and held it in 15 quarters.
- Panagora Asset Management's SANGAMO THERAPEUTICS INC position peaked at $10.2M in Q4 2020.
- 188 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2022.
Based on Panagora Asset Management's 13F filing for Q2 2022, filed 15 Aug 2022.